Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Financial News

Hatteras names Witty partner

September 19, 2017 6:21 PM UTC

Hatteras Venture Partners named Andrew Witty a venture partner on Tuesday. He retired as CEO of GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) in March (see BioCentury Extra, March 17, 2016).

Witty joined GSK in 1985 and became CEO in 2008. Emma Walmsley succeeded Witty as CEO of GSK when he retired (see BioCentury Extra, Sept. 20, 2016)...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article